Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
31 studies found for:    "benign essential blepharospasm" OR "Blepharospasm"
Show Display Options
RSS Create an RSS feed from your search for:
"benign essential blepharospasm" OR "Blepharospasm"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting rTMS and Botulinum Toxin in Benign Essential Blepharospasm
Condition: Benign Essential Blepharospasm
Interventions: Device: Magstim RapidStim2;   Device: Sham Magstim RapidStim2
2 Completed Brain Changes in Blepharospasm
Condition: Blepharospasm
Intervention:
3 Completed Brain Stimulation to Treat Blepharospasm or Meige Syndrome
Conditions: Blepharospasm;   Focal Dystonia
Intervention: Procedure: repetitive transcranial magnetic stimulation (rTMS)
4 Recruiting Comparison of Different Botulinum Toxin A Injection Patterns in the Treatment of Blepharospasm
Condition: Blepharospasm
Interventions: Procedure: Botulinum toxin A injection (5 sites: 12.5U);   Procedure: Botulinum toxin A injection (4 sites: 10U);   Drug: Botulinum toxin A 12.5U;   Drug: Botulinum toxin A 10U
5 Completed Comparison of Korean Botulinum Toxin Type A Versus Botox in the Treatment of Essential Blepharospasm
Condition: Blepharospasm
Intervention: Drug: Korean Botulinum toxin type A (KbtxA) and Botox injection
6 Completed Trial Evaluating Xeomin® (incobotulinumtoxinA) for Cervical Dystonia or Blepharospasm in the United States
Conditions: Cervical Dystonia;   Blepharospasm
Intervention: Biological: Xeomin®
7 Completed Study of a Single Administration of 3 Doses of Dysport® for the Treatment of Benign Essential Blepharospasm
Condition: Blepharospasm
Intervention: Drug: Botulinum toxin type A (Dysport®)
8 Recruiting Blepharospasm Tools
Conditions: Blepharospasm;   Dystonia;   Other Eye and Face Disorders
Intervention: Other: No intervention.
9 Completed Blepharospasm Patient Survey for Patients With Blepharospasm
Condition: Blepharospasm
Intervention: Other: No intervention- only one time survey
10 Terminated Blepharospasm Short Interval
Condition: Blepharospasm
Intervention: Drug: NT 201
11 Not yet recruiting Two Different Surgical Methods of Blepharospasm
Condition: Blepharospasm
Interventions: Procedure: Facial nerve combing;   Procedure: Facial and Trigeminal nerve combing
12 Completed
Has Results
IncobotulinumtoxinA (Xeomin) Versus Placebo in the Treatment of Blepharospasm
Condition: Blepharospasm
Interventions: Drug: incobotulinumtoxinA (Xeomin);   Drug: Placebo
13 Completed Efficacy and Safety Study of Meditoxin® to Treat Essential Blepharospasm
Condition: Essential Blepharospasm
Intervention: Drug: Botulinum Toxin Type A
14 Completed Therapeutic Confirmatory Clinical Trial to Evaluate the Safety and Efficacy of "Hugeltox Inj." in Essential Blepharospasm
Condition: Essential Blepharospasm
Interventions: Drug: Hugeltox;   Drug: Botulinum Toxin Type A(Botox®)
15 Completed
Has Results
Comparison of Two Botulinum Type A Products in the Treatment of Blepharospasm
Condition: Blepharospasm
Interventions: Biological: Botulinum Toxin Type A 900kDa;   Biological: Botulinum Toxin Type A 150kDa
16 Completed
Has Results
A Retrospective Chart Review of BOTOX® and Xeomin® for the Treatment of Cervical Dystonia and Blepharospasm
Conditions: Cervical Dystonia;   Blepharospasm
Intervention: Other: No Intervention
17 Completed A Retrospective Chart Review of BOTOX® and Xeomin® for the Management of Cervical Dystonia and Blepharospasm
Conditions: Cervical Dystonia;   Blepharospasm
Intervention: Other: No Intervention
18 Recruiting An RCT of a Patient-initiated Treatment Service for BEB and HFS
Conditions: Blepharospasm;   Hemi Facial Spasm
Intervention: Other: Patient-initiated treatment
19 Active, not recruiting Efficacy and Safety Study of Botulinum Toxin Type A Against Placebo to Treat Abnormal Contraction or Twitch of the Eyelid
Condition: Bilateral Blepharospasm (BEB)
Interventions: Drug: IncobulinumtoxinA (Xeomin), 25 Units;   Drug: IncobotulinumtoxinA (Xeomin), 12.5 Units;   Drug: Placebo;   Drug: IncobotulinumtoxinA (Xeomin), 35 Units
20 Unknown  Testing the Effect of Zinc Supplementation to Improve the Treatment Effect of Botulinum Toxin for Oculofacial Spasm
Conditions: Blepharospasm;   Hemifacial Spasm
Interventions: Drug: Zinc Supplement;   Drug: Sugar pill

   Previous Page Studies Shown (1-20) Next Page (21-31) Show next page of results    Last Page
Indicates status has not been verified in more than two years